Related Experiment Videos
Editorial
1Asthmatic and Allergy Inflammation Group, School of Medicine, University of Aberdeen UK.
Therapeutics and Clinical Risk Management
|May 20, 2008
Summary
No abstract available in PubMed .
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma.
Antibodies (Basel, Switzerland)·2025
Same author
Therapeutics and Clinical Risk Management - 20<sup>th</sup> Anniversary.
Therapeutics and clinical risk management·2025
Same author
Recent developments in the use of monoclonal antibodies targeting the type 2 cytokines for severe asthma treatment.
Advances in pharmacology (San Diego, Calif.)·2023
Same author
Molecular Biology of Eosinophils: Introduction.
Methods in molecular biology (Clifton, N.J.)·2021
Same author
Anti-IL-5 monoclonal antibodies for the treatment of asthma: an update.
Expert opinion on biological therapy·2020
Same journal
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange versus Oropharyngeal Airway-Assisted Face-Mask Ventilation for Gastric Insufflation During Induction of General Anesthesia in Patients at High Risk for Obstructive Sleep Apnea.
Therapeutics and clinical risk management·2026
Same journal
Blood-Based Inflammatory and Metabolic Biomarkers for Assessing Symptom Burden and Quality of Life in Older Adults with Cancer: A Narrative Review.
Therapeutics and clinical risk management·2026
Same journal
The Future of Interventional Keratoconus Management: Perspectives on Integrating Epithelium-on Oxygen-Enriched Cross-Linking into Comprehensive Care Pathways.
Therapeutics and clinical risk management·2026
Same journal
Transcranial Magnetic Stimulation Combined with Speech-Language Therapy for Post-Stroke Aphasia Recovery: A Systematic Review and Network Meta-Analysis.
Therapeutics and clinical risk management·2026
Same journal
Risk Factors for Hypoglycemia in Type 2 Diabetes Mellitus Patients Using Once-Weekly Semaglutide: A Matched Case-Control Study.
Therapeutics and clinical risk management·2026
Same journal
Extracellular Vesicle-Based Strategies for the Prevention of Chemotherapy-Induced Cardiotoxicity.
Therapeutics and clinical risk management·2026